Safety and Utility of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery
Otolaryngology–Head and Neck Surgery · 2023-09 · 169 (3) · 598-605
DOI: 10.1002/ohn.324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 06.04.2023. Verfasst von Nergis C Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Carbon Dioxide, Insufflation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Objective
Transnasal humidified rapid‐insufflation ventilatory exchange (THRIVE) is gaining acceptance as a safe method for apneic ventilation and oxygenation during laryngeal procedures, but remains controversial during laser laryngeal surgery (LLS) due to the theoretical risk of airway fire. This study describes our experience with THRIVE during LLS. Study Design Retrospective cohort study.
Setting
Stanford University Hospital, October 15, 2015 to June 1, 2021.
Methods
Retrospective chart review of patients ≥18 years who underwent LLS involving the CO 2 or KTP laser with THRIVE as the primary mode of oxygenation.
Results
A total of 172 cases were identified. 20.9% were obese (BMI ≥ 30). Most common operative indication was subglottic stenosis. The CO 2 laser was used in 79.1% of cases. Median lowest intraoperative SpO 2 was 96%. 44.7% cases were solely under THRIVE while 16.3% required a single intubation and 19.2% required multiple intubations. Mean apnea time for THRIVE only cases was 32.1 minutes and in cases requiring at least one intubation 24.0 minutes ( p < .001). Mean apnea time was significantly lower for patients who were obese ( p < .001) or had a diagnosis of hypertension ( p = .016). Obese patients and patients with hypertension were 2.03 and 1.43 times more likely to require intraoperative intubation, respectively. There were no intraoperative complications or fires since the institution of our LLS safety protocol.
Conclusion
By eliminating the fuel component of the fire triangle, THRIVE can be safely used for continuous delivery of high FiO 2 during LLS, provided adherence to institutional THRIVE‐LLS protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
- Department of Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA.
- Department of Anesthesiology, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Neelaysh Vukkadala
Zitieren
APA
Khan, N. C., Vukkadala, N., Saxena, A., Damrose, E. J., Nekhendzy, V., & Sung, C. K. (2023). Safety and Utility of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery. Otolaryngology–Head and Neck Surgery, 169(3), 598-605. https://doi.org/10.1002/ohn.324
Vancouver
Khan NC, Vukkadala N, Saxena A, Damrose EJ, Nekhendzy V, Sung CK. Safety and Utility of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery. Otolaryngology–Head and Neck Surgery. 2023;169(3):598-605. doi:10.1002/ohn.324
BibTeX
@article{Khan2023,
author = {Khan, Nergis C and Vukkadala, Neelaysh and Saxena, Amit and Damrose, Edward J and Nekhendzy, Vladimir and Sung, C Kwang},
title = {Safety and Utility of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
volume = {169},
number = {3},
pages = {598--605},
doi = {10.1002/ohn.324}
}
EUVIMED